Related Experiment Video
Updated: May 13, 2026
04:19
Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
Accelerated fracture healing with teriparatide
João Lindolfo C Borges1, Anderson Freitas, John P Bilezikian
1Universidade Católica de Brasília, Brasília, DF, Brazil. jlborges@metabolismo.com.br
Arquivos Brasileiros De Endocrinologia E Metabologia
|March 26, 2013
Summary
Osteoporosis therapies like bisphosphonates and teriparatide do not harm fracture healing. Emerging anabolic agents show promise for improving bone repair in osteoporotic fractures.
Area of Science:
- Orthopedics
- Pharmacology
- Bone Biology
Background:
- Osteoporotic fractures significantly impact patient recovery and quality of life.
- Effective management of osteoporosis is crucial for bone health and fracture prevention.
Observation:
- Bisphosphonates in experimental models show increased callus size, mineralization, and mechanical strength.
- Teriparatide has demonstrated mixed but potentially positive effects on fracture healing.
- Sclerostin and DKK1 antibodies show beneficial effects on fracture healing in development.
Findings:
- Current osteoporosis therapies do not negatively impact fracture healing.
- Bisphosphonates may improve implant fixation and fracture repair.
- Anabolic osteoporosis agents show promising experimental evidence for enhanced fracture healing.
Implications:
- Osteoporosis treatments appear safe for fracture healing, with some potentially beneficial.
- Further research into anabolic agents could lead to improved fracture repair strategies.
- These findings support the continued use of osteoporosis therapies alongside fracture management.
